Trials / Completed
CompletedNCT06060145
Effect of Indoor Plants on Cardiopulmonary System
Effect of Indoor Plants on Cardiopulmonary System: a Randomized, Crossover, Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Lina Zhang · Other Government
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized controlled human exposure crossover study, aims to explore the health benefits of indoor plants on cardiopulmonary system on adults.
Detailed description
The researchers will conduct a randomized cross-controlled trial involving 48 healthy adults in Hangzhou, China. These participants will be randomly assigned into two groups, each comprising 24 individuals. Each participant will undergo two separate exposures in an office setting: one exposure without any plants present, and another exposure with 34 to 38 potted plants. A washout period of at least 4 weeks will be implemented between the two exposures. Questionnaires, physical examinations and the collection of biological samples will be conducted prior to exposure and after exposure. In addition, the monitoring of negative air ion, air pollutants and noise exposure, as well as collection of environmental microbial samples, will be conducted on weekdays. Researchers will gather samples of blood, urine, nasal secretion, and exhaled breath condensate from participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Plants placed in an office environment | The intervention group will be provided with an intervention consisting of 34-38 potted plants arranged in an office environment for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks. |
| OTHER | Devoid of any plant presence in an office environment | Participants assigned to the control group will be exposed to an office environment devoid of any plant presence for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks. |
Timeline
- Start date
- 2023-12-21
- Primary completion
- 2024-03-29
- Completion
- 2024-03-31
- First posted
- 2023-09-29
- Last updated
- 2024-07-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06060145. Inclusion in this directory is not an endorsement.